Royal College of Surgeons in Ireland
Browse

File(s) under embargo

5

month(s)

11

day(s)

until file(s) become available

ncRNAs as biomarkers and therapeutic targets for bronchiectasis

journal contribution
posted on 2023-10-06, 16:37 authored by Catherine GreeneCatherine Greene

According to a recent statement from the Global Alliance for Chronic Diseases (Lung Diseases group) the effective management of chronic lung disease requires timely and accurate diagnosis. Whilst lack of access to appropriate standard diagnostics is a key barrier to the implementation of guideline-care for chronic obstructive lung disease (COPD), for example, especially in low and middle income countries, the problem is global. Compared to COPD, this is even more pronounced for bronchiectasis. There is a paucity of tools to test for bronchiectasis and clearly new methods to diagnose this disease are much needed; non-coding RNAs (ncRNA) hold great potential to fulfill this role.

History

Comments

The original article is available at https://www.futuremedicine.com/

Published Citation

Greene CM. ncRNAs as biomarkers and therapeutic targets for bronchiectasis. Epigenomics. 2023;15(15):755-757.

Publication Date

16 August 2023

PubMed ID

37584220

Department/Unit

  • Beaumont Hospital
  • Clinical Microbiology

Publisher

Future Medicine

Version

  • Accepted Version (Postprint)